GenVec - GNVC Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GenVec - GNVC

GNVC 7.193

0.0%

Jun 26 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Gary Mohilner	11/22/2014 4:35:19 PM
	Read Replies (1) of 106

I don't know if anyone here is following posts on I-Hub, and I'll not try to copy the links, but if you go there you'll find both a video on the first patient dosed, as well as Novartis's latest publicity on GNVC's drug. I was thrilled with the fact that Novartis is being so public about a drug that's in very early stage clinical trials. To me this shows a great deal of faith in the product. I also found it interesting that the Principle Investigator has been involved with the drug for 17 years, a check of his biography showed that in 2002 to 2005 he worked on a grant that GNVC partially funded. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next